← Back to Search

New-Onset Diabetes Mellitus for Pancreatic Cancer (PANDOME Trial)

N/A

Recruiting

Led By Richard Frank, MD

Research Sponsored by Nuvance Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 3 years

Awards & highlights

No Placebo-Only Group

Summary

The main goal of this study is to explore the relationship between new-onset diabetes mellitus/deteriorating diabetes and a subsequent diagnosis of pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for pancreatic cancer.

Eligible Conditions

Pancreatic Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, up to 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, up to 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Early Stage Pancreatic Cancer or Precursor Lesions

Secondary study objectives

Relative Risk of Pancreatic Cancer Among Individuals with Detiorating diabetes

Relative Risk of Pancreatic Cancer Among Individuals with New-Onset Diabetes

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: New-Onset Diabetes MellitusExperimental Treatment1 Intervention

Diabetes Mellitus diagnosed within the past 12 months

Group II: Deteriorating Diabetes MellitusExperimental Treatment1 Intervention

History of Diabetes Mellitus with recent deteriorating within the past 6 months confirmed with repeat testing and not associated with weight gain or diabetes medication non-compliance

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityOTHER

1,926 Previous Clinical Trials

3,030,532 Total Patients Enrolled

Nuvance HealthLead Sponsor

3 Previous Clinical Trials

400 Total Patients Enrolled

Richard Frank, MD4.529 ReviewsPrincipal Investigator - Nuvance Health

Nuvance Health

2 Previous Clinical Trials

400 Total Patients Enrolled

5Patient Review

I was already a big fan of Dr. Richard Frank before I even met him, thanks to his excellent book on cancer. He's extremely knowledgeable and has always been very approachable, which makes me feel safe. I'm grateful to have found such a treasure in my own backyard.